Back to Search Start Over

Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy.

Authors :
Barbanente, Alessandra
Palazzo, Barbara
Esposti, Lorenzo Degli
Adamiano, Alessio
Iafisco, Michele
Ditaranto, Nicoletta
Migoni, Danilo
Gervaso, Francesca
Nadar, Robin
Ivanchenko, Pavlo
Leeuwenburgh, Sander
Margiotta, Nicola
Source :
Journal of Inorganic Biochemistry. Feb2021, Vol. 215, pN.PAG-N.PAG. 1p.
Publication Year :
2021

Abstract

In the present study we have studied the incorporation and release of selenite ions (SeO 3 2−) in hydroxyapatite nanoparticles for the treatment of bone tumors. Two types of selenium-doped hydroxyapatite (HASe) nanoparticles (NPs) with a nominal Se/(P + Se) molar ratio ranging from 0.01 up to 0.40 have been synthesized by a new and mild wet method. The two series of samples were thoroughly characterized and resulted to be slightly different in chemical composition, but they had similar properties in terms of morphology and degree of crystallinity. Selenium release from HASe was investigated under neutral and acidic conditions to simulate both healthy tissues and the low-pH environment surrounding a tumor mass, respectively. The comparison of the release profiles at two pH values clearly showed the possibility of modulating the Se release by simply changing the amount of Se in the HASe particles. The correlation between the physicochemical properties of HASe and their dissolution as a function of pH has been also investigated to facilitate future application of the NPs as chemotherapeutic adjuvant agents. Finally, the cytotoxic activity of HASe was evaluated using prostate (PC3) and breast (MDA-MB-231) cancer cells as well as healthy human bone marrow stem cells (hBMSc). HASe NPs exerted a good cytocompatibility at low concentration of Se but, with high Se doping concentration, they displayed strong cytotoxicity. Selenium-doped hydroxyapatite (HASe) nanoparticles for potential treatment of bone tumors were effectively doped with Se up to 13%wt by a mild and green synthesis. In vitro ions' release and cytotoxicity studies have shown that HASe with high Se-doping exert cytotoxicity on cancer but also on healthy cells. Unlabelled Image • Se-doped hydroxyapatite (HASe) nanoparticles for potential treatment of bone tumors. • Hydroxyapatite was effectively doped with Se up to 13%wt by a mild and green synthesis. • HASe with low crystallinity resembling the physico-chemical properties of bone mineral. • HASe with high Se doping exerts cytotoxicity on cancer cells but also on healthy cells. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01620134
Volume :
215
Database :
Academic Search Index
Journal :
Journal of Inorganic Biochemistry
Publication Type :
Academic Journal
Accession number :
148141584
Full Text :
https://doi.org/10.1016/j.jinorgbio.2020.111334